A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1994
10/11/1994	CA1332415C 1,2,3,4-tetrahydroisoquinoline antiarrhythmic agents
10/11/1994	CA1332414C Camptothecin derivatives and process for preparing same
10/11/1994	CA1332411C Benzodiazepine analogs
10/11/1994	CA1332410C Benzodiazepine analogs
10/11/1994	CA1332358C Nutritional supplement containing lithium
10/11/1994	CA1332357C Treating agent for peripheral circulatory disturbances
10/11/1994	CA1332353C Pharmaceutical composition for the treatment of skin wounds
10/11/1994	CA1332351C Method for preventing tissue damage after an ischemic episode
10/11/1994	CA1332350C Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
10/11/1994	CA1332307C Mineral supplements with sugar alcohol
10/10/1994	CA2121003A1 Basic ethers and process for the preparation thereof
10/10/1994	CA2120990A1 Trisubstituted cycloalkane derivatives and process for the preparation thereof
10/10/1994	CA2120861A1 Pharmaceutical compounds
10/06/1994	DE4410136A1 Tumoricidal T lymphocytes
10/06/1994	DE4314976C1 Transdermal therapeutic systems for the administration of drugs, process for their production and their use
10/06/1994	DE4311806A1 Use of arginine derivatives as quisqualate antagonists
10/06/1994	CA2120424A1 Anti-osteopathic composition
10/05/1994	EP0618226A1 Inhibitors of herpes viral ribonculeotide reductase
10/05/1994	EP0618223A2 Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents
10/05/1994	EP0618221A2 Heterocyclic inhibitors of farnesyl protein transferase
10/05/1994	EP0618214A1 Unsaturated phosphonate derivatives of purines and pyrimidines
10/05/1994	EP0618209A1 Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them
10/05/1994	EP0618207A1 Substituted pyridopyrimidines as antihypertensives
10/05/1994	EP0618206A1 Pharmaceutical compounds
10/05/1994	EP0618203A1 3-O-acylated catechins and method of producing same
10/05/1994	EP0618201A1 Thiadiazinones and their use in the treatment of cardiovascular or asthmatic conditions
10/05/1994	EP0618198A1 Process for the preparation of 1,3-bis (1,2,4-triazol-1-yl)-propan-2-ol derivatives
10/05/1994	EP0618197A1 Synthesis of CIS-decahydroisoquinoline-3-carboxylic acids
10/05/1994	EP0618196A1 Stereocontrolled synthesis of cis-bicyclic compounds
10/05/1994	EP0618194A1 3-Phenyl-1,2,5,6-tetrahydropyridine and its use as a sedative
10/05/1994	EP0618193A1 Nitrogen containing bicyclic derivatives as prolyl-endopeptidase inhibitors
10/05/1994	EP0618190A1 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
10/05/1994	EP0618001A1 Process for preparing active agents containing spherules
10/05/1994	EP0617968A1 HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS
10/05/1994	EP0617963A1 Lipid metabolism improving medicinal composition
10/05/1994	EP0617962A1 Obesity inhibitor
10/05/1994	EP0617960A1 Use of pyridoxal derivatives for the manufacture of a medicament for the treatment of cataract
10/05/1994	EP0617959A1 Pharmaceutical for the treatment of skin disorders
10/05/1994	EP0617958A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions
10/05/1994	EP0617957A1 Oral formulations of ubidecarenone in form of capsules
10/05/1994	EP0617956A2 Anti-inflammatory analgesic plaster containing Piroxicam
10/05/1994	EP0617705A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them.
10/05/1994	EP0617625A1 Use of udpg as cancer therapy rescue agent
10/05/1994	EP0617623A1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
10/05/1994	EP0617622A1 Use of renin inhibitors for the treatment of glaucoma
10/05/1994	EP0617621A1 Central cholecystokinin antagonists having pharmaceutical activity
10/05/1994	EP0617620A1 Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
10/05/1994	EP0617619A1 Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis
10/05/1994	EP0617618A1 Aryl-triflates and related compounds
10/05/1994	EP0617617A1 Compositions containing histamine-h2-receptor antagonists at low dosage
10/05/1994	EP0617616A1 Potentiation of nmda antagonists
10/05/1994	EP0617615A1 Pharmaceutical composition and process for the preparation thereof
10/05/1994	EP0617614A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/05/1994	EP0617609A1 Lipid-soluble thioethers and dithioethers in cosmetic preparations to counteract aging of the human skin
10/05/1994	EP0539460B1 Salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii b
10/05/1994	EP0538337B1 Drug for reducing intraocular pressure
10/05/1994	EP0533695B1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
10/05/1994	EP0520016B1 Derivatives of urea, their preparation and medicaments containing them
10/05/1994	EP0482100B1 Novel vitamin d analogues
10/05/1994	EP0422178B1 Pyrimidine derivatives
10/05/1994	CN1093089A Cephalosporin salts and process for the preparation thereof
10/05/1994	CN1093087A Serotoninergic ergoline derivatives
10/05/1994	CN1093085A Amine derivatives
10/05/1994	CN1093084A Rhenium and technetium complexes containing a hypoxia-localizing moiety
10/05/1994	CN1093082A N,N-disubstituted arylcycloalkylamines, the salts thereof, pharmaceutical compositions containing these compounds...
10/05/1994	CN1092980A Crystalline amifostine compositions and mthods for the preparation and use of same
10/05/1994	CN1092979A Pharmaceutical composition for inhibiting the infection with aids virus
10/05/1994	CN1092978A Granular delayed capsule
10/05/1994	CN1026115C Novel S-adenosyl methionine inhibitors
10/05/1994	CN1026112C Preparation of tertiar hydroxyalkylxanthin
10/05/1994	CN1026111C Quinuclidine therapeutic agents
10/05/1994	CN1026110C Antihypercholesterolemic tetrazole compound
10/05/1994	CN1026108C Novel 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same
10/05/1994	CN1026063C Preparation of pharmaceutical composition containing substituted thienoimidazol derivative
10/04/1994	US5352832 Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
10/04/1994	US5352815 Agent for suppression and interception of mailard reaction
10/04/1994	US5352811 Method of preparing alkanoyloxytetrodecanoic acid by assymmetric allylboratron
10/04/1994	US5352810 Transesterification of diethylphosphonate or phosphoric triester with trimethylsilylbromide, treating with myoinositol protected at certain hydroxy groups in presence of condensing agent, removal of protecting groups
10/04/1994	US5352808 Process for steroid preparation
10/04/1994	US5352806 Anticarcinogenic agents
10/04/1994	US5352805 Water soluble derivatives of taxol
10/04/1994	US5352804 Isolation and structure of Halistatin 2
10/04/1994	US5352798 Process for preparing dithio-ethylanino 9A-methoxymitosanes
10/04/1994	US5352792 Thioalkylthio cephalosporin derivatives
10/04/1994	US5352790 Process for the preparation of 1β-ethyl-1α-(hydroxymethyl)-1,2,3,4,6,7,12,12Bα-octahydro-indolo[2,3,-A]quinolizine and novel intermediates
10/04/1994	US5352784 Fused cycloalkylimidazopyridines
10/04/1994	US5352708 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
10/04/1994	US5352707 Asthma, rhinitis
10/04/1994	US5352705 Dipeptide-based amide compounds; anticarcinogenic agents
10/04/1994	US5352703 Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
10/04/1994	US5352702 Oral administration of unsaturated ketone derivatives of aryloxyacetic acid
10/04/1994	US5352701 Leukotriene-B4 antagonist compounds and their use as pharmaceutical agents
10/04/1994	US5352700 Using gammalinolenic acid or other fatty acids with 18-20 carbon atoms; topical application
10/04/1994	US5352699 Use of retinioc acid to treat vaginal atrophy
10/04/1994	US5352698 Methods of treatment for patients suffering from Riley-Day disease
10/04/1994	US5352695 Use of lysine pyrrolidone carboxylate and/or of arginine pyrrolidone carboxylate as an antoxidant substance in cosmetic or pharmaceutical compositions
10/04/1994	US5352694 Pharmaceutical agents
10/04/1994	US5352693 A solid dispersion of at least one alkyl ester of para-hydroxy benzoic acid in a hydroxymethyl-substituted dimethylhydantoin
10/04/1994	US5352692 Inhibitors of thromboxane synthetase
10/04/1994	US5352691 Effective treatment modality for adult respiratory distress syndrome using L-histidine

1 ... 7076 7077 7078 7079 7080 7081 7082 7083 7084 7085 7086 7087 7088 7089 7090 7091 7092 7093 7094 7095 7096 ... 7860